Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’

Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’

Bibliographic Details
Main Authors: Mike Bastian, Nick Freemantle, Ana B. Rossi, Brad Shumel, Gaelle Bego Le Bagousse, Zhixiao Wang, Yingxin Xu, Patricia Guyot
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-02-01
Series:Dermatology and Therapy
Subjects:
Atopic dermatitis
Dupilumab
Eczema
Lebrikizumab
Matching-adjusted indirect comparison
Online Access:https://doi.org/10.1007/s13555-024-01106-2

Internet

https://doi.org/10.1007/s13555-024-01106-2

Similar Items